Keymed Biosciences Inc. (2162.HK)

HKD 33.0

(-1.93%)

Operating Expenses Summary of Keymed Biosciences Inc.

  • Keymed Biosciences Inc.'s latest annual operating expenses in 2023 was 317.21 Million CNY , up 30.62% from previous year.
  • Keymed Biosciences Inc.'s latest quarterly operating expenses in 2024 Q2 was 222.11 Million CNY , down 0.0% from previous quarter.
  • Keymed Biosciences Inc. reported a annual operating expenses of 575.74 Million CNY in annual operating expenses 2022, up 30.0% from previous year.
  • Keymed Biosciences Inc. reported a annual operating expenses of 442.88 Million CNY in annual operating expenses 2021, up 226.93% from previous year.
  • Keymed Biosciences Inc. reported a quarterly operating expenses of 222.11 Million CNY for 2024 Q2, down 0.0% from previous quarter.
  • Keymed Biosciences Inc. reported a quarterly operating expenses of 223.89 Million CNY for 2023 Q3, up 50.92% from previous quarter.

Annual Operating Expenses Chart of Keymed Biosciences Inc. (2023 - 2019)

Historical Annual Operating Expenses of Keymed Biosciences Inc. (2023 - 2019)

Year Operating Expenses Operating Expenses Growth
2023 317.21 Million CNY 30.62%
2022 575.74 Million CNY 30.0%
2021 442.88 Million CNY 226.93%
2020 135.46 Million CNY 101.57%
2019 67.2 Million CNY 0.0%

Peer Operating Expenses Comparison of Keymed Biosciences Inc.

Name Operating Expenses Operating Expenses Difference
Uni-Bio Science Group Limited 325.05 Million HKD 2.41%
CK Life Sciences Int'l., (Holdings) Inc. 739.25 Million HKD 57.09%